These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 35155178)

  • 1. An MRI-Based Radiomics Model for Predicting the Benignity and Malignancy of BI-RADS 4 Breast Lesions.
    Zhang R; Wei W; Li R; Li J; Zhou Z; Ma M; Zhao R; Zhao X
    Front Oncol; 2021; 11():733260. PubMed ID: 35155178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preoperative prediction of HER-2 expression status in breast cancer based on MRI radiomics model].
    Zhang Y; Huang H; Yin L; Wang ZX; Lu SY; Wang XX; Xiang LL; Zhang Q; Zhang JL; Shan XH
    Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):428-437. PubMed ID: 38742356
    [No Abstract]   [Full Text] [Related]  

  • 3. Fully automatic classification of breast lesions on multi-parameter MRI using a radiomics model with minimal number of stable, interpretable features.
    Zhang J; Zhan C; Zhang C; Song Y; Yan X; Guo Y; Ai T; Yang G
    Radiol Med; 2023 Feb; 128(2):160-170. PubMed ID: 36670236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiomics Based on DCE-MRI Improved Diagnostic Performance Compared to BI-RADS Analysis in Identifying Sclerosing Adenosis of the Breast.
    Ruan M; Ding Z; Shan Y; Pan S; Shao C; Xu W; Zhen T; Pang P; Shen Q
    Front Oncol; 2022; 12():888141. PubMed ID: 35646630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-modality radiomics nomogram based on DCE-MRI and ultrasound images for benign and malignant breast lesion classification.
    Liu X; Zhang J; Zhou J; He Y; Xu Y; Zhang Z; Cao G; Miao H; Chen Z; Zhao Y; Jin X; Wang M
    Front Oncol; 2022; 12():992509. PubMed ID: 36531052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of radiomics models for tumour-infiltrating lymphocyte (TIL) prediction in breast cancer: the role of the dynamic contrast-enhanced (DCE) MRI phase.
    Tang WJ; Kong QC; Cheng ZX; Liang YS; Jin Z; Chen LX; Hu WK; Liang YY; Wei XH; Guo Y; Jiang XQ
    Eur Radiol; 2022 Feb; 32(2):864-875. PubMed ID: 34430998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of combined clinical-radiomics model based on contrast-enhanced MRI in predicting the malignancy of breast non-mass enhancements without an additional diffusion-weighted imaging sequence.
    Li Y; Yang Z; Lv W; Qin Y; Tang C; Yan X; Yin T; Ai T; Xia L
    Quant Imaging Med Surg; 2023 Sep; 13(9):5974-5985. PubMed ID: 37711822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
    Zhang M; Horvat JV; Bernard-Davila B; Marino MA; Leithner D; Ochoa-Albiztegui RE; Helbich TH; Morris EA; Thakur S; Pinker K
    J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Validation of a Radiomics Nomogram for Predicting Clinically Significant Prostate Cancer in PI-RADS 3 Lesions.
    Li T; Sun L; Li Q; Luo X; Luo M; Xie H; Wang P
    Front Oncol; 2021; 11():825429. PubMed ID: 35155214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra- and Peritumoral Based Radiomics for Assessment of Lymphovascular Invasion in Invasive Breast Cancer.
    Jiang W; Meng R; Cheng Y; Wang H; Han T; Qu N; Yu T; Hou Y; Xu S
    J Magn Reson Imaging; 2024 Feb; 59(2):613-625. PubMed ID: 37199241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiomics Nomogram Based on Dual-Sequence MRI for Assessing Ki-67 Expression in Breast Cancer.
    Zhang L; Shen M; Zhang D; He X; Du Q; Liu N; Huang X
    J Magn Reson Imaging; 2024 Sep; 60(3):1203-1212. PubMed ID: 38088478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiomics Based on Multimodal MRI for the Differential Diagnosis of Benign and Malignant Breast Lesions.
    Zhang Q; Peng Y; Liu W; Bai J; Zheng J; Yang X; Zhou L
    J Magn Reson Imaging; 2020 Aug; 52(2):596-607. PubMed ID: 32061014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of noncontrast MRI in evaluating breast imaging reporting and data system category 0 lesions on digital mammograms.
    Zhang R; Xu M; Zhou C; Ding X; Lu H; Ge M; Du L; Bu Y
    Quant Imaging Med Surg; 2022 Aug; 12(8):4069-4080. PubMed ID: 35919041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiparameter MRI Radiomics Model Predicts Preoperative Peritoneal Carcinomatosis in Ovarian Cancer.
    Yu XY; Ren J; Jia Y; Wu H; Niu G; Liu A; Gao Y; Hao F; Xie L
    Front Oncol; 2021; 11():765652. PubMed ID: 34790579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of breast MRI omics features and clinical characteristics in Breast Imaging Reporting and Data System (BI-RADS) category 4 breast lesions: an analysis of radiomics-based diagnosis.
    Cui Q; Sun L; Zhang Y; Zhao Z; Li S; Liu Y; Ge H; Qin D; Zhao Y
    Ann Transl Med; 2021 Nov; 9(22):1677. PubMed ID: 34988186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Application of MRI-based Radiomics Models in the Assessment of Hepatic Metastasis of Rectal Cancer].
    Hu SX; Yang K; Wang XR; Wen DG; Xia CC; Li X; Li ZL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Mar; 52(2):311-318. PubMed ID: 33829708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-Enhanced Spectral Mammography-Based Radiomics Nomogram for Identifying Benign and Malignant Breast Lesions of Sub-1 cm.
    Lin F; Wang Z; Zhang K; Yang P; Ma H; Shi Y; Liu M; Wang Q; Cui J; Mao N; Xie H
    Front Oncol; 2020; 10():573630. PubMed ID: 33194677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI-based radiomics analysis to predict preoperative lymph node metastasis in papillary thyroid carcinoma.
    Hu W; Wang H; Wei R; Wang L; Dai Z; Duan S; Ge Y; Wu PY; Song B
    Gland Surg; 2020 Oct; 9(5):1214-1226. PubMed ID: 33224796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-Mass Enhancements on DCE-MRI: Development and Validation of a Radiomics-Based Signature for Breast Cancer Diagnoses.
    Li Y; Yang ZL; Lv WZ; Qin YJ; Tang CL; Yan X; Guo YH; Xia LM; Ai T
    Front Oncol; 2021; 11():738330. PubMed ID: 34631572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bi-parametric magnetic resonance imaging based radiomics for the identification of benign and malignant prostate lesions: cross-vendor validation.
    Ji X; Zhang J; Shi W; He D; Bao J; Wei X; Huang Y; Liu Y; Chen JC; Gao X; Tang Y; Xia W
    Phys Eng Sci Med; 2021 Sep; 44(3):745-754. PubMed ID: 34075559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.